Ikarian Capital, LLC

13F Holdings History for RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD)

Symbol: RLMD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 par value per share
Latest Disclosed Ownership: 3.54M shares
Security Ownership: 4.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Ikarian Capital, LLC ownership in RELMADA THERAPEUTICS, INC. Common Stock, par value $0.001 par value per share (RLMD)

2025-11-14 - Ikarian Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.54M shares of RELMADA THERAPEUTICS, INC. Common Stock, par value $0.001 par value per share (RLMD). This represents 4.8% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Ikarian Capital, LLC	4.8%		$7.12M	3.54M			$2.01	13G	9/30/2025	14 Nov 2025 18:28:02

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		0.84%	+0.82%	$3.7M	1.84M	+1,802,790	+4477%	$2.01	Q3 2025
6/30/2025		0.01%		$24.2K	40.3K			$0.60	Q2 2025
3/31/2025		0%		$10.9K	40.3K			$0.27	Q1 2025
12/31/2024		0.01%	0%	$20.9K	40.3K	-99	-0.25%	$0.52	Q4 2024
9/30/2024		0.04%		$131K	40.4K			$3.24	Q3 2024
6/30/2024		0.04%		$121K	40.4K			$3.00	Q2 2024
3/31/2024		0.05%		$188K	40.4K			$4.65	Q1 2024
12/31/2023		0.05%		$167K	40.4K			$4.14	Q4 2023
9/30/2023		0.01%		$121K	40.4K			$3.00	Q3 2023
6/30/2023		0.03%		$161K	65.5K			$2.46	Q2 2023
3/31/2023		0.03%		$148K	65.5K			$2.26	Q1 2023
12/31/2022		0.06%	+0.06%	$229K	65.5K	+65,491	NEW	$3.49	Q4 2022
12/31/2022	call		-5.73%	$0	0	-775,300	-100%		Q4 2022
12/31/2022	put		-5.73%	$0	0	-775,300	-100%		Q4 2022
9/30/2022	call	5.72%	+3.51%	$28.7M	775K	+475,300	+158%	$37.02	Q3 2022
9/30/2022	put	5.72%	+3.64%	$28.7M	775K	+493,000	+175%	$37.02	Q3 2022
6/30/2022			-0.08%	$0	0	-21,801	-100%		Q2 2022
6/30/2022	call	1.04%	+1.04%	$5.7M	300K	+300,000	NEW	$18.99	Q2 2022
6/30/2022	put	0.98%	+0.98%	$5.36M	282K	+282,300	NEW	$18.99	Q2 2022
3/31/2022		0.08%	+0%	$588K	21.8K	+1,058	+5.1%	$26.97	Q1 2022
12/31/2021		0.07%		$467K	20.7K			$22.51	Q4 2021
9/30/2021		0.12%	-1.32%	$544K	20.7K	-279,464	-93.1%	$26.23	Q3 2021
9/30/2021	call		-0.96%	$0	0	-203,400	-100%		Q3 2021
6/30/2021		1.72%	+0.05%	$9.61M	300K	+10,000	+3.45%	$32.01	Q2 2021
6/30/2021	call	0.96%	+0.01%	$6.51M	203K	+5,800	+2.94%	$32.01	Q2 2021
3/31/2021		1.52%	+0.45%	$10.2M	290K	+290,207	NEW	$35.21	Q1 2021
3/31/2021	call	0.3%		$6.96M	198K	+197,600	NEW	$35.21	Q1 2021
6/30/2020			-0.14%	$0	0	-55,172	-100%		Q2 2020
3/31/2020		0.14%	+0.14%	$1.88M	55.2K	+55,172	NEW	$34.11	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.